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ABSTRACT 
Deep Vein Thrombosis and pulmonary embolism (DVT/PE) is one of the most 
common causes of unexpected death for hospital in-patients. D-dimer is used as a 
biomarker within blood for the diagnosis of DVT/PE. We report a low-cost microfluidic 
device with a conveniently biofunctionalised interdigitated electrode (IDE) array and a 
portable impedimetric reader as a point-of-care (POC) device for the detection of D-
dimer to aid diagnosis of DVT/PE. The IDE array elements, fabricated on a 
polyethylenenaphtalate (PEN) substrate, are biofunctionalised in situ after assembly of 
the microfluidic device by electropolymerisation of a copolymer of polypyrrole to 
which is immobilised a histidine tag anti-D-Dimer antibody. The most consistent 
copolymer films were produced using chronopotentiometry with an applied current of 
5A for a period of 50 seconds using a two-electrode system. The quality of the 
biofunctionalisation was monitored using optical microscopy, chronopotentiometry 
curves and impedimetric analysis. Measurement of clinical plasma sample with a D-
dimer at concentration of 437 ng/mL with 15 biofunctionalised IDE array electrodes 
gave a ratiometric percentage of sample reading against the blank with an average 
value of 124±15 at 95% confidence. We have demonstrated the concept of a low cost 
disposable microfluidic device with a receptor functionalised on the IDE array for 
impedimetric detection towards POC diagnostics. Changing the receptor on the IDE 
array would allow this approach to be used for the direct detection of a wide range of 
analytes in a low cost manner. 
Key words: Impedimetric sensing; electropolymerisation; interdigitated electrodes; 
point-of-care diagnostics; microfluidics  
1.0 Introduction  
Venous thromboembolism (VTE) is a condition in which the blood clots inappropriately 
and causes considerable morbidity and mortality in all ethnicity, genders and ages 
(Beckman et al., 2010). VTE is a disease which can manifest as either pulmonary 
embolism (PE) or deep vein thrombosis (DVT)(Lopez, 2004). PE is often accompanied 
by, or preceded by the development of DVT (Chan and Ginsberg, 2002). VTE is the third 
most common life-threatening cardio vascular disease in the USA (Cushman et al., 
2004) and with many of the known risk factors (advanced age, immobility, surgery, 
obesity) increasing within society it is a growing public health concern. Venography is 
considered to be the gold standard method of diagnosing DVT but this is an invasive 
procedure (Bucek et al., 2001). Alternative non-invasive techniques including doppler 
ultrasound and computed tomography (CT) (Srivastava et al., 2004) are relatively time 
consuming and expensive to perform.  
The fragments of a clot are called fibrin degradation products (FDP) and one of these is 
D-dimer which consists of two cross-linked D fragments of the fibrinogen protein 
(Bourigua et al., 2010). Elevated levels of D-dimer is indicative of numerous conditions 
(including VTE) that lead to the activation of coagulation and fibrin formation 
(Ghanima and Sandset, 2007). There has been a growing interest in the development 
of D-dimer based enzyme-linked immunosorbent assays (ELISAs). Although D-dimer 
based ELISAs have demonstrated a high sensitivity and negative predictive value (NPV) 
they are also extremely labour intensive, time consuming and are designed for batch 
analysis (Božič et al., 2002). D-dimer electrochemical ELISA’s have been demonstrated 
on microfluidic devices (Rossier and Girault, 2001) with the antibodies immobilised to 
the surface of a photo-ablated microchannel prior to D-dimer interaction. The 
detection in this instance uses a secondary HRP labelled antibody for the enzymatic 
conversion of hydroquinone in the presence of hydrogen peroxide. This sensor yields a 
detection limit of ~100pM and a dynamic range (0.1-100nM) three orders of 
magnitude larger. This is of particular clinical interest as the cut off range for early 
stage thrombosis/embolism is around 400ng/mL (2nM). Despite the promise of this 
microfluidic electrochemical ELISA, it still suffers from problems such as the need of a 
secondary labelled antibody, which can influence the cost and ease of the 
measurement.  
Direct electrochemical detection of D-dimer could be achieved through various 
transducers.   Potentiometric detection of D-dimer has been demonstrated with silver 
nanoparticles decorated ZnO nanotubes (Ibupoto et al., 2013), ZnO nanorod (Ibupoto 
et al., 2014) and graphene (Nikoleli et al., 2014). Impedimetric detection has been 
demonstrated to offer several advantages such as, ease of use, rapid and sensitive 
response (Prodromidis, 2010; Santos, 2014). A key advantage of using impedance over 
many other methods is the potential ability to perform direct label-free detection. 
Most other methods attach a label (e.g. fluorophore or chromophore) to the target 
and the label is then detected and related to the amount of bound targets. Use of a 
label on a biomolecule has the drawback of altering its binding properties and the 
target-label coupling reaction can be variable, which can be a particular issue for 
protein targets.  A label can allow higher selectivity and or sensitivity but this is often 
at the expense of additional cost, time and sample handling. Several impedimetric 
immunosensors have been reported for D-dimer detection that involved SWCNTs 
(Bourigua et al., 2010), MWCNTs (Chebil et al., 2013), and Chitosan/Gold nanoparticle 
(Rodrigues et al., 2018). We have previously described impedimetric immunosensor 
detection using conducting copolypyrrole film to which a histidine tag antibody has 
been bound using a complex NTA chelator coordinated with copper as metal. A model  
antigen was determined in the range of 0.1-10ng/mL by measuring the charge transfer 
resistance (Rct) of the biolayer at the reduction potential of copper (Hafaid et al., 
2010). We subsequently demonstrated the detection of D-dimer in the range of 0.1-
500 ng/mL, with a limit of detection of 100pg/mL (Chebil et al., 2010).  
The integration of biosensors into microfluidic devices with array of electrodes and 
reader able to convert the biological information of detection remains a significant 
challenge for development of POC systems (Rackus et al., 2015). There are few 
examples of POC system integrating such components. These include a system with 
DNA amplification and detection chambers with two electrode array (Ferguson et al., 
2009) and a microfluidic system with microelecrode array based on amperometric 
competitive immunoassay for prostate specific antigen (Triroj et al., 2011). A further 
example includes DNA detection based on integrated biosensors modified with 
MWCNTs and where the integration in microfluidic system improves the sensitivity of 
detection and leads to a lower detection limit (Zribi et al., 2016).  
Here we describe use of an array of IDEs within a microfluidic cartridge manufactured 
using high volume and low-cost approach and a portable impedimetric reader for 
immunosensor D-dimer detection. The biofunctionalisation approach of the IDEs is 
based on electropolymerized polypyrrole and antibody immobilization through 
NTA/Copper complex. This allows the individual functionalisation of the array elements 
through electrochemical patterning of polypyrrole. The overall approach adopted has 
potential for the development of a low cost POC system for the detection of D-dimer 
for DVT/PE. Changing the immobilised receptor and the electric field, through 
modifying the IDE transducer configuration, would allow this to be developed as a 
generic low cost diagnostic approach for direct monitoring of a wide variety of 
ligand/receptor binding events. This could include use of aptamers for small molecules 
to DNA/RNA hybridisation to the detection of viruses and bacteria (2-5m particles). 
2.0 Materials and Methods 
2.1 Instrumentation 
Electropolymerisation of the electrodes and electrochemical measurements were 
performed using the Auto LAB potentiostat/galvanostat (Eco Chemie B.V.) in 
conjunction with General Purpose Electrochemical System (GPES) software and 
Frequency Response Analyzer (FRA) software (Eco Chemie B.V.) for 
electropolymerisation/cyclic voltammetry (CV) and electrochemical impedimetric 
measurements respectively.  
A portable impedimetric reader system was developed for the microfluidic cartridge 
with IDE array but a separate connector frame was designed and fabricated for the 
preliminary measurements and for the biofunctionalisation processes. The connector 
frame included two red LEDs (powered by a 9V battery) to allow quick connection and 
accurate alignment of the microfluidic cartridge with the spring-loaded connector pins 
(Figure 1A) with the AUTOLAB system for the polymerisation process and analysis of 
the functionalised bio-layer. The meander shaped working electrodes were individually 
addressed for connection, whilst the interdigitated fingers (counter electrodes) were 
grouped as a single connection.  
2.2 Microfluidic cartridge with IDE array 
The microfluidic cartridge comprises a three-layer structure with a microfluidic channel 
layer and electrode layer that are joined by an adhesive layer (Figure 1). The 
microfluidic channel layer was fabricated from a polycarbonate sheet (3.0mm) by hot 
embossing (Jenoptik Mikrotechnik Hex 02).  
The electrode layer comprised a five element IDE array (30µm finger width and 
spacing), four resistive elements for fluid localisation and two platinum temperature 
sensor elements on a 125µM PEN sheet. Gold electrodes were fabricated by physical 
vapour deposition (PVD) by sputtering a 250 nm gold layer (Au) with subsequent 
patterning using photolithography as described previously (Kuphal et al., 2012). An 
extra metal layer (e.g. chrome or titanium), to promote metal adhesion, was not 
necessary in this case as the gold was found to adhere sufficient well directly to the 
polymer. Each set of IDEs consisted of two interdigitated electrodes as the counter 
electrode and a third ‘meander’ electrode which is employed as the working electrode 
in the system. The temperature is determined by measuring the resistance of platinum 
electrode incorporated on the PEN substrate. A constant current is driven through the 
resistor and the voltage drop across the resistor is measured using a 4-wire set-up so 
that the error caused by the resistance of the measuring wire is eliminated.  
The electrode and microfluidic channel layers were joined in a two-step lamination 
process using an optical alignment system with a 50µM thick double-sided adhesive 
tape (AR care 8890, Adhesive Research Ireland Ltd), primarily chosen for its high shear 
strength. The adhesive tape was laser cut with the outer contour of the microfluidic 
cartridge and the inner contour of the microfluidic channel.      
 2.3 Electropolymerisation 
Prior to electropolymerisation, the IDE array in the microfluidic cartridge was rinsed 
three times with pure ethanol to remove any material from the electrode surface. 
Electropolymerisation was performed using both chronoamperometry and 
chronopotentiometry (galvanostatic) approaches. Monomer solution (8mM pyrrole 
(Py)/ 2mM Nhydroxyphtalimide pyrrole (PyNHP)/0.5M LiClO4 in ethanol) was placed in 
the microfluidic chamber with the IDE array. Chronoamperometry was performed at 
0.9V vs. Ag/AgCl reference electrode (external to the microfluidic cartridge) for 200 
seconds or until a maximum charge of 11mC/cm2 was obtained to give the copolymer 
films (Py-PyNHP). Chronopotentiometry was performed at 5µA for 50 and 100 
seconds. In all cases, after electropolymerisation of the IDE array, the microfluidic 
cartridge was rinsed with ethanol three times to remove excess monomer solution, 
followed by rinsing with deionised water three times. 
An increase in the sensor sensitivity was attempted by increasing the surface area 
using gold nano-particles (Au-NP). A solution of 0.5M gold nanoparticles (K2Au(CN)6) in 
PBS was injected into the microfluidic chamber, Au-NPs were deposited onto the IDEs 
using chronoamperometry. In order to deposit AuNPs onto the IDEs by 
electrodeposition, a -1V potential was applied for 10 seconds followed by a 0V 
potential for a duration of 100 seconds and the procedure repeated twice. The IDEs 
were analysed using differential pulse voltammetry in a solution of 1mM K3Fe (CN)6/ 
1mM K4Fe (CN)6 in PBS.   
2.4 Bio-functionalisation Process 
The formation of the bio-layer (SI figure 1) on the IDE array within the microfluidic 
device was achieved by firstly injecting 7mM (pH 9) NαNα-Bis(carboxylmethyl)-L-lysine 
hydrate (NTA) in PBS into the microfluidic cartridge for one hour in order to attach the 
ligand NTA group to  the PyNHP group in the polymerised film. The microfluidic 
cartridge was again rinsed three times with deionised water prior to the formation of 
the NTA/Cu2+ complex, which was achieved by injecting 3.5mM copper acetate in the 
microfluidic cartridge for 20 minutes. Residual copper was removed by rinsing three 
times with deionised water before immobilization of a histidine tagged anti-D-dimer 
antibody (8µg/ml) for 30 minutes. Casein (50µg/ml) was used to block the remaining 
surface to prevent non-specific absorption. Analysis of the formed bio-layer was 
performed using electrochemical impedimetric measurements in PBS buffer (applied 
potential 0V).  
2.5 Clinical measurements 
A plasma sample containing D-dimer was taken from a clinical sample pool at a 
concentration of 437 ng/ml and validated with Pathfast Immunoanalyser (Mitsubishi 
Chemical Europe). Measurements were made with the in-house developed portable 
impedimetric reader into which is inserted the microfluidic cartridge with 
biofunctionalised IDE array. First, baseline measurements were made on the IDE array 
in the microfluidic cartridge. The electrolyte was then washed and replaced by the 
clinical sample for 15 minutes incubation.  
3.0 Results and Discussion 
3.1 Portable impedimetric reader system 
The in-house developed portable impedimetric reader was based on the AD5933 chip 
from Analog Devices. The excitation signal over the 20 Hz - 10,000 Hz range was 
covered with 4 adjustable amplitudes (20, 40, 100 and 200 mV). The usable 
(presettable) mesurement ranges were the charge resistance (Rct) = 4,7 or 10 or 100 or 
470 kOhm and double layer capacitance (Cdl) = 220, 470, 100 and 68 nF. The portable 
device was capable of measuring biofunctional layers with similar ranges of values. 
Between the 100 kOhm - 1 MOhm Rct range of a PCB dummy of biosensor layer charge 
transfer resistance our device had ca. 2% error in each of the 5 measurement channels 
(IDEs) and with the relative standard deviations of ca. 0.5 % for 1MOhm and 0-0.01 % 
for the 100 kOhm. The input ports of the circuitry are connected to the five working 
electrodes (WEs) of the microfluidic cartridge via an inverting amplifier and an analog 
matrix switch. The input ports of the circuitry can be connected to any of the working 
electrodes individually or to all of them simultaneously. The DC voltage of the working 
electrodes is adjusted by a D/A convertor connected to the non-inverting input port of 
the amplifier. The impedance measurement unit was also used to measure the 
impedance of four pairs of fill sensors that are integrated within the microfluidic 
cartridge. The measurement is based on Nyquist plot followed by fitting of data with 
equivalent circuits where the Rct is in parallel with Cdl and all in series with Rs as the 
resistance of solution. The Warburg impedance is not observed since at high 
frequencies, the Warburg impedance is small given that the diffusing reactants are not 
required to move very far. In addition, the small dimension of the electrode as well as 
the small volume chamber improve diffusion that could be similar to spherical one. 
The impedimetric reader includes a liftable tray to provide the fluidic and electric 
connections with the microfluidic cartridge. Contact between the electrodes 
integrated in the microfluidic cartridge and the impedimetric reader is achieved by 
means of 2 rows of spring-tip electrodes. The liftable tray functions to align the 
microfluidic cartridge in working position, prevent its’ movement and ejection after 
the assay is completed. The impedimetric reader makes fluidic contact of buffer 
solution with the microfluidic cartridge by means of a needle, which penetrates a 
resilient septum on the microfluidic body. The fluidic contact was sufficiently tight for 
single use of the microfluidic cartridge as is the intended use. 
3.2 Fabrication of the DVT/PE POC microfluidic cartridge 
A key objective for the fabrication approach for the polymer microfluidic cartridge with 
the impedimetric IDE array was for development of a device that would have potential 
for high volume and low-cost manufacture. Moreover, the use of an impedimetric IDE 
array has the advantage of either replicate measurements of a single biomarker in the 
microfluidic cartridge and or detection of multiple biomarkers. The IDE array fabricated 
on a PEN polymer substrate offers the potential for high volume and low-cost 
manufacture using a roll-to-roll or other high volume single sheet processes. The 
microfluidic channel layer was fabricated using hot embossing that can be used for 
volume production of devices. For higher volume production of devices then the hot 
embossing approach could be substituted with a micro-injection moulding approach.  
A major challenge for assembly of the polymer microfluidic cartridge was for accurate 
alignment which for the channel and electrode geometry was required over a distance 
of more than 55mm and is beyond what is normally required for Si chip bonding. For a 
polymer based device this is made more difficult because of the poorer dimensional 
stability of polymers with the chemical and thermal changes that will arise due to the 
lithographic processing of the electrode layer and the hot embossing for the 
microfluidic channel layer. The dimensional variance of the polymer microstructure 
makes the alignment a more critical element if a mismatch of the layers is to be 
avoided with the associated distortion of the channel geometries and disturbance of 
the fluid flow properties. The accuracy of the alignment was determined by the 
position of the resistive electrodes, incorporated for liquid fill sensing, with respect to 
the microfluidic channel. The more significant mismatch arose from the thermal 
shrinkage of the polycarbonate microfluidic channel layer during the hot embossing 
process.   The assembly approach was able to achieve an alignment accuracy of 
34±19µm in the lateral and 34±18µm in the horizontal directions. The microfluidic 
cartridge was able to hold fluid without any leakage. More generally, however, it is 
clear that an intermediate laminate bonding film can be an appropriate approach for 
creation of a hybrid material system where the two materials are incompatible for 
thermal or solvent bonding but independently have desirable manufacturing and 
performance characteristics.   
The contact pads for the IDE array, flow control electrodes for fill sensing and 
temperature sensor are situated at the long edges of the microfluidic cartridge. At 
these edges, the electrode layer is wider than the microfluidic body which allows 
access of the impedimetric reader to the contact pads and functional integration and 
control of the electrodes by the reader. A septum is attached to the microfluidic body 
by means of an adhesive. Care needs to be taken that the surface of the microfluidic 
body is smooth over the whole surface area of the septum to avoid leakage of liquid. 
3.3 Electropolymerisation and biofunctionalisation of the IDE array in the microfluidic 
cartridge 
Functionalisation of the IDE array could be carried out either before or after bonding of 
the PEN IDE array layer with the microfluidic channel layer. We adopted to 
functionalise within the microfluidic cartridge since this has the advantage of 
passivation of the electrodes which makes it easier to select the individual IDE 
elements for functionalisation. A drawback is, however, that the IDE array elements 
within a microfluidic cartridge have significantly higher resistivity values.  The 
previously described chronoamperometry approach (Chebil et al., 2010; Hafaid et al., 
2010) used for polymerisation on IDEs within the microfluidic cartridge showed large 
differences for the different IDEs. Subsequent biofunctionalisation of the IDEs also 
resulted in very different Nyquist plots for the different IDEs which will have arisen in 
significant part from the variability of the initial electropolymerisation process.  Thus, 
an alternative chronopotentiometry (galvanostatic) polymerisation approach was 
investigated using an applied current of 5A for periods of 50 and 100 seconds with an 
external reference electrode. From the polymerisation curves, a constant current at 
100 seconds seemed to show better reproducibility as shown in the curves of variation 
of potential within time for the IDEs in the microfluidic cartridge (Figure 2). After 
biofunctionalisation, DPV was used to measure the redox signal of copper complex 
where an more apparent oxidation peak for Cu2+ ion was obtained in the case of 100s 
time polymerisation (SI figure  2).  
In respect of the detection properties, impedimetric analysis, however, showed a 
decrease in the charge transfer resistance, observed by decrease of diameter of the 
Nyquist semi-circle, with addition of D-dimer protein (1ng/ml and 0.1µg/ml) for IDEs 
formed with constant current at 100 seconds against an increase in charge transfer 
region for a biolayers formed with application of a constant current at 50 seconds 
(Figure 3). An increase in charge transfer resistance can be expected with addition of 
antigen since there will be additional resistance to electron transfer arising from the 
complex antigen-antibody formation. The thick film of polypyrrole formed with 100s 
time appears less sensitive to the complex formation. This result is in concordance of 
the previous published work with polypyrrole as transducer where it was 
demonstrated that thin films are more sensitive to biocomplex formation (Korri-
Youssoufi and Yassar, 2001). As a consequence, further studies for the formation of the 
biolayer on IDEs using chronopotentiometry employed a constant current of 5A for 
50 seconds. It should also be noted that there is a negligible difference in the charge 
transfer between addition of antigen from 1ng/ml to 0.1g/ml. This is ascribed to a 
saturation of the biosensor element so that there are insufficient available antibodies 
to bind with the higher concentration of antigens. 
Electro-deposition of Au-NPs was performed in order to study the effect of increasing 
the surface to volume ratio on the biolayer sensitivity. This approach attempts to 
improve sensor surface and also facilitate electron transfer as demonstrated 
previously (Tertiş et al., 2017). The Au-NP coated IDE showed an approximate four 
times increase in the surface compared to the untreated electrode surface as 
demonstrated with the intensity variation of redox current  of SWV obtained with 
K3Fe(CN)6 redox couple (SI figure 3A). The electro-deposition also resulted in a shift in 
the peak potentials of Fe2+/Fe3+  redox couple at lower potential of 300 mV compared 
to untreated IDE. This is attributed to a higher electron transfer ability obtained after 
deposition of Au-NPs that increases both the surface to volume ratio and also the 
conductivity of the surface electrode compared to the untreated IDE. Subsequent 
biofunctionalisation and addition of D-dimer antigen, however, showed no increase in 
the charge transfer after complex formation (SI figure 3B). This is attributed to an 
increase of the surface density of the polypyrrole layer on the IDE electrode and 
consequently a higher density of the antibody attached leading to steric effects. As a 
result of this, Au-NPs were not further employed for biofunctionalisation within the 
microfluidic cartridge for the clinical sample measurements.                
The biofunctionalised IDE arrays were tested with varying concentrations of D-dimer 
using DPV (SI figure 4). A decrease of the current density corresponding to the redox 
probe signal for the Cu2+/Cu+ indicates good fixation of the D-dimer antigen on the anti 
D-dimer antibody. We also studied the effect of potentially interfering molecules 
present in blood with the biofunctionalised IDE array. Non-specific responses from 
relatively high concentration of haemoglobin, billubirin, heparin and triglyceride were 
found to be modest indicating specificity of the antibody and effectiveness of the 
treatment of the biolayer by casein to prevent non-specific interaction.   
3.4 Reproducibility of biofunctionalisation on microfluidic IDEs array  
Reproducibility of the functionalised IDEs within the microfluidic cartridge was higher 
by electropolymerisation using a two-electrode system than with a three-electrode 
system, which includes an external Ag/AgCl reference electrode (Figure 4). It is thought 
that the relatively small spacing between the IDE fingers negates the requirement for a 
reference electrode. Electropolymerisation using the two electrode system was 
therefore chosen for all further development. A number of publications have 
previously demonstrated conductimetric detection on IDEs without the use of a 
reference electrode (Anh et al., 2004; Jaffrezic-Renault and Dzyadevych, 2008; Khadro 
et al., 2008; Marrakchi et al., 2005).  
The quality of biofunctionalisation is dependent on the quality of the surface of the 
bare IDEs and this could be ascertained through optical microscope images of the IDEs. 
Figure 5 (I) shows bare IDEs with either contamination or residual connection between 
the counter and working electrodes arising from incomplete etching, the latter giving 
rise to flat polymerisation curves. This can lead to biofunctionalisation of the meander 
which is patchy or inhomogeneous as opposed to a uniform green coating that is 
obtained from IDEs with a good surface quality. The errors that arise in the operation 
of the microfluidic cartridge will be a combination of errors from the three main steps 
in the manufacture of the microfluidic cartridge, namely: manufacture of IDEs, 
assembly of the microfluidic cartridge and biofunctionalisation. The potential over the 
electropolymerisation cycle (50 seconds) was used as a metric for measuring the 
quality for each individual IDE. For 11 microfluidic cartridges that were manufactured it 
was found that 35 IDEs had an RSD of within 17% for the measured 
electropolymerisation curves and 45 IDEs with an RSD of within 20%, this was higher 
than the best case within a single microfluidic cartridge. The electropolymerisation 
curves showed good similarities for IDEs two to five but a high level of inconsistencies 
for IDE one within the different microfluidic cartridges which is likely to arise from the 
IDE fabrication process. The inconsistencies for IDE one compared with the other IDEs 
was also subsequently indicated through the different impedimetric response of the 
bio-functionalised IDEs (Figure 6).  
3.5 Clinical sample measurement 
To demonstrate operation of the impedimetric reader with a microfluidic cartridge, 
containing the biofunctionalised IDEs, we tested the system with a middle range 
concentration of D-dimer in frozen plasma. The impedimetric reader follows a defined 
protocol for the clinical measurements. Firstly, the temperature of the cartridge is 
measured to check that this does not differ from predefined values. Baseline 
measurements are made in blank buffer (electrolyte) solution and measured values for 
the solution resistance (Rs), charge transfer resistance (Rctblank) and double layer 
capacitance (Cdl) were determined from Nyquist plot measured with the developed 
reader. The clinical sample is then inserted into the sample reservoir of the 
microfluidic cartridge and pumped over the IDE array and left there for 15 minutes for 
ligand receptor binding. Buffer solution was then pumped via the septum on the 
microfluidic cartridge from a buffer reservoir to push back the clinical sample into the 
sample reservoir. This was used to clean the fluidic channel and minimise any 
interferents to the ligand receptor binding. The reader then makes further 
measurements for the Rs, Rctsample and Cdl.  
Given the previously determined inconsistencies for IDE one, this was not used for the 
measurement of D-dimer concentration within the clinical sample. As a means of 
improving the measurement accuracy the remaining four IDEs were used to make 
repeat measurements of D-dimer binding. Clinical samples containing D-dimer at a 
concentration of 437 ng/mL were measured over a total of 15 IDEs in different 
cartridges with a ratiometric percentage of sample reading against the blank with an 
average value of 124±15 with 95% confidence.  This demonstrates that the developed 
microfluidic cartridge and impedimetric reader system is able to recognise D-dimer at 
a middle range concentration for IDEs within the microfluidic cartridge. Using the same 
receptor on each of the five IDE array elements within a single microfluidic cartridge 
will allow replication of measurements with internal standardisation and the potential 
for higher level of accuracy. Further work will be required to optimise fabrication of 
the microfluidic cartridge to increase the reproducibility and decrease the failure rates 
as well as higher volume of testing for linearisation and quantification of this approach.   
4.0 Conclusion 
An array of biofunctionalised IDEs, within a microfluidic cartridge, and a portable 
impedimetric reader can be used for the measurement of D-dimer at a middle range 
concentration of a clinical plasma sample. The quality and reliability of the 
manufactured microfluidic cartridges can be monitored through a combination of 
optical microscopy, chronopotentiometry polymerisation curves and impedimetric 
analysis.   
Biofunctionalisation with modified polypyrrole of the IDE array can be carried out in 
situ within a polymer microfluidic cartridge using chronopotentiometry with a 5µA 
current for a 50 second period and a two-electrode system with good reproducibility 
with RSD around 20%.  This allows the immobilisation of His tag D-dimer antibody 
through NTA/ cooper complex attached to polypyrrole layer. The microfluidic cartridge 
was used to measure D-dimer in clinical sample at 437ng/mL using an impedimetric 
reader without amplification step and with results obtained in 15 minutes.  
Future work will focus on improving the fabrication approach to increase 
reproducibility and decrease failure rates of the microfluidic cartridges for low cost 
label-free impedimetric POC diagnostics. Tailoring of the receptor on the IDE array 
would allow this approach to be applicable to a wide variety of diagnostic applications 
using impedimetric detection and without amplification. 
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Figure 1 Photograph of the DVT/PE reader & alignment system (A) schematic 
representation of the IDE impedimetric array (B) microfluidic cartridge and (C) the  












































Figure 2 Chronopotentiometry ploymerization curves (5µA) for (A) 100 seconds (B) 50 
seconds 







































































Figure 3 Nyquist plots showing the functionalised bio-layer and antibody-antigen 
interactions after polymerisation (A) 100 seconds (B) 50 seconds. 
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 Figure 4 Electropolymerisation curves within microfluidic cartridge using (A) three 
electrode and (B) two electrode system. 
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Figure 5 Microscope optical images of (I) bare IDEs showing (A) contamination (B) 
residual connections between the working and counter electrodes as result of 
incomplete etching (C) good quality (II) IDEs where meander has been bio-
functionalised (A) meander delamination after deposition (B) inhomogeneous coating 








































Figure 6 Nyquist plot showing the inconsistent biofunctionalisation of IDE one against 
the other IDEs within a typical microfluidic cartridge 
 
Highlights 
 Biofunctionalisation of IDE array in microfluidic device with 
electropolymerisation 
 Portable impedimetric reader for detection of D-dimer biomarker 
 Quality of biofunctionalisation monitored using optical microscopy 
 Properties of biofunctionalised layers using chronopotentiometry and 
impedance 
 Measurement of clinical plasma sample of four biofunctionalised IDEs  
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